![Mike Read](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mike Read
Plus aucun poste en cours
Profil
Mike Read was the founder and was the Chief Operating Officer at Astrego Diagnostics AB, which was founded in 2017.
He also held the position of Executive Vice President at Ginolis Oy.
Anciens postes connus de Mike Read
Sociétés | Poste | Fin |
---|---|---|
Astrego Diagnostics AB
![]() Astrego Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden. | Fondateur | - |
Ginolis Oy
![]() Ginolis Oy Medical SpecialtiesHealth Technology Ginolis Oy develops and provides disposable test platforms for the global diagnostic and medical technology industries. The firm offers production and laboratory automation solutions for manufacturing, laboratories and end-user instruments. The company was founded by Teijo Ilkka Sakari Fabritius and Matti Ahti Koivu in 2010 and is headquartered in Oulunsalo, Finland. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 2 |
---|---|
Ginolis Oy
![]() Ginolis Oy Medical SpecialtiesHealth Technology Ginolis Oy develops and provides disposable test platforms for the global diagnostic and medical technology industries. The firm offers production and laboratory automation solutions for manufacturing, laboratories and end-user instruments. The company was founded by Teijo Ilkka Sakari Fabritius and Matti Ahti Koivu in 2010 and is headquartered in Oulunsalo, Finland. | Health Technology |
Astrego Diagnostics AB
![]() Astrego Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden. | Commercial Services |